title: Prognosis for dogs with nonlymphomatous, small intestinal tumors treated by surgical excision.
abstract: Long-term follow-up information was obtained for 39 dogs that had undergone surgical excision of nonlymphomatous, small intestinal tumors. For all dogs evaluated in this study, the median survival time was 10 months, and the one- and two-year survival rates were 40.5% and 33.1%, respectively. There was no difference in survival times between dogs with adenocarcinomas (n=23) and dogs with leiomyosarcomas (n=16). Survival times were significantly (p less than 0.0001) shorter for dogs with histological evidence of metastases at the time of surgery (median, 3.0 months) than for dogs with no histiological evidence of metastases (median, 15.0 months).
authors.affiliation: Department of Veterinary Surgery, Tufts University, North Grafton, Massachusetts 01536, USA.
authors.forename: J
authors.initials: J
authors.lastname: Crawshaw
authors.forename: J
authors.initials: J
authors.lastname: Berg
authors.forename: J C
authors.initials: JC
authors.lastname: Sardinas
authors.forename: S J
authors.initials: SJ
authors.lastname: Engler
authors.forename: W M
authors.initials: WM
authors.lastname: Rand
authors.forename: G K
authors.initials: GK
authors.lastname: Ogilvie
authors.forename: G J
authors.initials: GJ
authors.lastname: Spodnick
authors.forename: D A
authors.initials: DA
authors.lastname: O'Keefe
authors.forename: D M
authors.initials: DM
authors.lastname: Vail
authors.forename: R A
authors.initials: RA
authors.lastname: Henderson
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000601:surgery / Q000662:veterinary*; D000818:Animals; D004283:Dog Diseases / Q000601:surgery*; D004285:Dogs; D005500:Follow-Up Studies; D007414:Intestinal Neoplasms / Q000473:pathology / Q000601:surgery / Q000662:veterinary*; D007421:Intestine, Small / Q000601:surgery; D007890:Leiomyosarcoma / Q000473:pathology / Q000601:surgery / Q000662:veterinary*; D011379:Prognosis; D013522:Surgery, Veterinary / Q000379:methods; D016019:Survival Analysis; D016896:Treatment Outcome